[go: up one dir, main page]

ES2164764T3 - Excipiente de liberacion sostenida. - Google Patents

Excipiente de liberacion sostenida.

Info

Publication number
ES2164764T3
ES2164764T3 ES95914917T ES95914917T ES2164764T3 ES 2164764 T3 ES2164764 T3 ES 2164764T3 ES 95914917 T ES95914917 T ES 95914917T ES 95914917 T ES95914917 T ES 95914917T ES 2164764 T3 ES2164764 T3 ES 2164764T3
Authority
ES
Spain
Prior art keywords
excipient
heteropolisacarido
approximately
weight
sustained liberation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95914917T
Other languages
English (en)
Inventor
Anand R Baichwal
Troy W Mccall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mendell Edward Co Inc
Original Assignee
Mendell Edward Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Edward Co Inc filed Critical Mendell Edward Co Inc
Application granted granted Critical
Publication of ES2164764T3 publication Critical patent/ES2164764T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superstructure Of Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN EXCIPIENTE DE LIBERACION PROLONGADA A UTILIZAR EN DOSIS SOLIDAS ORALES QUE INCLUYE DE UN 15 APROXIMADAMENTE A UN 30 POR CIENTO APROXIMADAMENTE O MAS EN PESO DE GOMA DE HETEROPOLISACARIDO; UNA CANTIDAD EFECTIVA DE UN AGENTE DE ENTRECRUZAMIENTO CATIONICO CAPAZ DE ENTRECRUZAR EL HETEROPOLISACARIDO EN UN ENTORNO DE USO; Y UNA SUSTANCIA DE RELLENO FARMACEUTICA INERTE.
ES95914917T 1994-04-25 1995-03-21 Excipiente de liberacion sostenida. Expired - Lifetime ES2164764T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25

Publications (1)

Publication Number Publication Date
ES2164764T3 true ES2164764T3 (es) 2002-03-01

Family

ID=22873888

Family Applications (2)

Application Number Title Priority Date Filing Date
ES01112778T Expired - Lifetime ES2246961T3 (es) 1994-04-25 1995-03-21 Excipiente de liberacion sostenida.
ES95914917T Expired - Lifetime ES2164764T3 (es) 1994-04-25 1995-03-21 Excipiente de liberacion sostenida.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES01112778T Expired - Lifetime ES2246961T3 (es) 1994-04-25 1995-03-21 Excipiente de liberacion sostenida.

Country Status (18)

Country Link
EP (2) EP1145712B1 (es)
JP (1) JP3279318B2 (es)
KR (1) KR100232020B1 (es)
CN (1) CN1131023C (es)
AT (2) ATE308318T1 (es)
AU (1) AU705378B2 (es)
CA (1) CA2164513C (es)
DE (2) DE69524358T2 (es)
DK (1) DK0706377T3 (es)
ES (2) ES2246961T3 (es)
FI (1) FI119353B (es)
HK (1) HK1040487B (es)
HU (1) HU219818B (es)
IL (1) IL113167A (es)
MX (1) MX9600022A (es)
PT (1) PT706377E (es)
TW (1) TW357085B (es)
WO (1) WO1995028916A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
AU2002316582B2 (en) 2001-07-06 2007-03-15 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
CA2459976A1 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
ES2246961T3 (es) 2006-03-01
HUT73636A (en) 1996-08-28
DE69524358T2 (de) 2002-06-13
MX9600022A (es) 1998-06-30
FI956209L (fi) 1995-12-22
EP0706377B1 (en) 2001-12-05
EP0706377A4 (en) 1996-11-06
HU219818B (hu) 2001-08-28
CN1127469A (zh) 1996-07-24
DK0706377T3 (da) 2002-04-02
DE69534575T2 (de) 2006-07-13
ATE308318T1 (de) 2005-11-15
JP3279318B2 (ja) 2002-04-30
CA2164513A1 (en) 1995-11-02
HK1040487B (zh) 2006-05-12
PT706377E (pt) 2002-05-31
EP1145712A1 (en) 2001-10-17
HU9503456D0 (en) 1996-02-28
KR100232020B1 (ko) 1999-12-01
FI956209A0 (fi) 1995-12-22
WO1995028916A1 (en) 1995-11-02
IL113167A0 (en) 1995-06-29
CN1131023C (zh) 2003-12-17
EP1145712B1 (en) 2005-11-02
TW357085B (en) 1999-05-01
EP0706377A1 (en) 1996-04-17
ATE209906T1 (de) 2001-12-15
JPH08512061A (ja) 1996-12-17
CA2164513C (en) 1999-09-21
AU2198295A (en) 1995-11-16
DE69534575D1 (de) 2005-12-08
FI119353B (fi) 2008-10-31
AU705378B2 (en) 1999-05-20
HK1040487A1 (en) 2002-06-14
DE69524358D1 (de) 2002-01-17
KR960703016A (ko) 1996-06-19
IL113167A (en) 2001-01-28

Similar Documents

Publication Publication Date Title
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
ECSP003835A (es) Composicion para dosis oral de liberacion extendida
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
ES2180574T3 (es) Formulaciones de liberacion controlada de oxibutinina.
AR006519A1 (es) Formula encapsulada de liberacion prolongada de clorhidrato de venlafaxina, una formula de pelicula de recubrimiento, y el uso de dicha formula encapsuladapara preparar una formulacion de liberacion prolongada
ES2101330T3 (es) Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado.
ES2195308T3 (es) Composicon farmaceutica de fenofibrato que presenta una biodisponibilidad elevada, y metodo para su preparacion.
AR024228A1 (es) Una composicion farmaceutica que comprende un sensibilizador de insulina y otro agente antidiabetico
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
SV1998000131A (es) Formulaciones de accion prolongada ref. ahp-95011-1-c1
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
ES2172592T3 (es) Agente antagonista de progesterona y agente gestageno para el tratamiento de la endometriosis y del liomioma uterino.
ES2091001T3 (es) Capsula que contiene un componente susceptible de degradacion y un polimero compuesto.
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
ES2164764T3 (es) Excipiente de liberacion sostenida.
ES2187038T3 (es) Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion.
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
BR9610930A (pt) Composição depilatória incluindo uma quantidade funcional de um agente tixoitrópico, e, uso da quantidade funcional de um agente tixotrópico.
CO5241355A1 (es) Forma envasada de composiciones farmaceuticas nucleosidicas activas para vacunas contra la hepatitis
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
ECSP003685A (es) Formulaciones orales de liberacion controlada
ES2113136T3 (es) Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 706377

Country of ref document: ES